GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Days Inventory

J.Molner AS (OTSE:MOLNR) Days Inventory : 0.00 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). J.Molner AS's Average Total Inventories for the six months ended in Dec. 2023 was €0.04 Mil. J.Molner AS's Cost of Goods Sold for the six months ended in Dec. 2023 was €-0.07 Mil.

The historical rank and industry rank for J.Molner AS's Days Inventory or its related term are showing as below:

During the past 3 years, J.Molner AS's highest Days Inventory was 29.74. The lowest was 29.74. And the median was 29.74.

OTSE:MOLNR's Days Inventory is not ranked *
in the Drug Manufacturers industry.
Industry Median: 159.275
* Ranked among companies with meaningful Days Inventory only.

J.Molner AS's Days Inventory stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year. J.Molner AS's Inventory Turnover for the six months ended in Dec. 2023 was -1.65.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. J.Molner AS's Inventory-to-Revenue for the six months ended in Dec. 2023 was 0.12.


J.Molner AS Days Inventory Historical Data

The historical data trend for J.Molner AS's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Days Inventory Chart

J.Molner AS Annual Data
Trend Dec21 Dec22 Dec23
Days Inventory
29.74 - -

J.Molner AS Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Days Inventory - - - - -

Competitive Comparison of J.Molner AS's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, J.Molner AS's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


J.Molner AS's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, J.Molner AS's Days Inventory distribution charts can be found below:

* The bar in red indicates where J.Molner AS's Days Inventory falls into.



J.Molner AS Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

J.Molner AS's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

Days Inventory (A: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (0.009 + 0.072) / 2 ) / -0.256*365
=0.0405 / -0.256*365
=N/A

J.Molner AS's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

Days Inventory (Q: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Jun. 2023 ) + Total Inventories (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (0.009 + 0.072) / 2 ) / -0.067*365 / 2
=0.0405 / -0.067*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


J.Molner AS  (OTSE:MOLNR) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

J.Molner AS's Inventory Turnover for the six months ended in Dec. 2023 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

J.Molner AS's Inventory to Revenue for the six months ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


J.Molner AS Days Inventory Related Terms

Thank you for viewing the detailed overview of J.Molner AS's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


J.Molner AS (OTSE:MOLNR) Business Description

Traded in Other Exchanges
N/A
Address
Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618
J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines